Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioSphere Medical Announces Year End and 4th Quarter 2002 Earnings Release.


Business Editors

ROCKLAND, Mass.--(BUSINESS WIRE)--Jan. 28, 2003

BioSphere biosphere, irregularly shaped envelope of the earth's air, water, and land encompassing the heights and depths at which living things exist. The biosphere is a closed and self-regulating system (see ecology), sustained by grand-scale cycles of energy and of  Medical (Nasdaq: BSMD), a medical device company that is pioneering the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply, will hold its quarterly conference call to discuss 4th quarter and year-end results on Thursday, January 30, 2003, at 11:00 a.m. Eastern Time (10 a.m. Central Time).

This call is being webcast by CCBN CCBN Central Coast Bancorp
CCBN Charles County Business Network
 and can be accessed at BioSphere Medical's web site at www.biospheremed.com.

The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

About BioSphere Medical, Inc.

BioSphere Medical, Inc., based in Rockland, Massachusetts Rockland is a town in Plymouth County, Massachusetts, United States. The population was 17,670 at the 2000 census. with 10,199 total registered voters as of December 31, 2005. , is a medical device company focused on embolotherapy, the treatment of tumors and vascular malformations by occluding their blood supply. The Company is pioneering the use of patented and proprietary bioengineered microspheres as a new class of embolics. BioSphere Medical has received approvals in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Canada and Australia which allow the Company to sell Embosphere(R) Microspheres for use in general embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun)
1. the process or condition of becoming an embolus.

2. therapeutic introduction of a substance into a vessel in order to occlude it.
 procedures, including uterine fibroid embolization Uterine Fibroid Embolization Definition

Uterine fibroids are growths in the muscular tissue of the womb (uterus). Uterine fibroid embolization is non-surgical removal of the growths through the use of a tubular device called a catheter.
, and has also received CE Mark approval in the European Community.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 28, 2003
Words:240
Previous Article:United Defense Earns Top Rating for Software Development at Santa Clara Facility.
Next Article:Fresh Del Monte Produce Inc. Conference Call - Tuesday, February 11, 2003 at 11:00 A.M. EST.
Topics:



Related Articles
BioSphere Medical Reports Third Quarter Financial Results; Worldwide Revenues Double and U.S. Revenues Triple Over Prior Year.
BioSphere Medical Reports Record Second Quarter 2002 Financial Results.
BioSphere Medical Announces Lawsuit by European Distributor.
BioSphere Medical Reports Fourth Quarter and Fiscal Year 2002 Financial Results.
BioSphere Medical, Inc. Reports Second Quarter 2003 Financial Results; Uterine Fibroid Embolization Awareness Program Underway and Making Progress.
CORRECTING and REPLACING BioSphere Medical, Inc. to Present at Rodman & Renshaw Techvest Fifth Annual Healthcare Conference Issued October 16, 2003.
BioSphere Medical Reports Third Quarter 2003 Financial Results; Company Updates Uterine Fibroid Embolization Awareness Progress.
BioSphere Medical Reports Fourth Quarter and Fiscal Year 2003 Financial Results.
BioSphere Medical Reports Second Quarter 2004 Financial Results.
BioSphere Medical to Present at Roth Capital Partners New York Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles